Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
PaperCitations, authors & open-access status
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 322 citations, 2021 year and hybrid oa status.
322
Citations
2021
Year
hybrid
OA Status